Clinical Trial Update: The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of ONO-7913 and ONO-4538 with standard-of-care as first-line treatment for unresectable colorectal cancer; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ONO-4538
• ONO-7913

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Unresectable Colorectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING